University Hospital Frankfurt-Dept.Obstetrics and Perinatal Medicine
Frankfurt am Main, Hesse, 60590, Germany
NCT Number: NCT02727452
The randomised study analyzes the effects of immediate bonding (skin-to-skin contact) on different psychobiological and somatic outcomes of mother and child. The investigators compare 3 bonding conditions. Cortisol and Oxytocin are also measured during the bonding process.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Frankfurt am Main, Hesse, 60590, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 and 60 minutes after bonding
Cortisol is assessed as a stress parameter by Saliva. It will be tested in the mother and child to measure the effect of immediate bonding with the mother compared to the other 2 conditions on the stress level
Time frame: 1-3 days and 6 weeks after childbirth
assessed by EPDS
Time frame: 1-3 days and 6 weeks after childbirth
assessed by PBQ
Time frame: 30 and 60 minutes after birth
Time frame: 30 and 60 minutes after birth
Time frame: 30 and 60 minutes after birth
Time frame: 30 and 60 minutes after birth
Saliva measurement
Johann Wolfgang Goethe University Hospital
Other
Effects of Immediate Bonding (Skin-to-skin Contact) During Caesarean Section- Psychobiological and Somatic Outcomes of Mother and Child
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03176459
Agnosia, C-Section
Loma Linda, California, United States
View Trial DetailsNCT03834415
C-Section
Mexico City, Tlalpan, Mexico
View Trial DetailsNCT07608341
C-Section
Helsinki, Finland
View Trial DetailsNCT05505110
C-Section, Microbiome
Nashville, Tennessee, United States
View Trial Details